Our recommendations help practitioners and commissioners get the best care to people, fast, while ensuring value for the taxpayer.
People living with spinal muscular atrophy (SMA) in England are set to gain routine access to two potentially life-changing treatments, following our publication of final draft guidance today.
The targeted treatment helps people live longer and can help prevent the disease from returning.
We’ve recommended that newborn babies receiving antibiotics in hospital could potentially switch to oral antibiotics and be cared for at home if they are doing well and responding to treatment.
Around 530 people in England will benefit from access to the Duchenne muscular dystrophy treatment givinostat, following the successful negotiation of a commercial deal to make the medicine available on the NHS.
Best practice resources for practitioners and commissioners.
Helping you define, improve and measure quality in health, public health and social care.
Resources and recommendations for adult and children’s social care, with example scenarios to help put them into practice.
Explore ways to plan, save money and make decisions on the best ways to use resources.
Useful sources of information and advice for healthcare professionals, patients, parents and carers.
The British National Formulary (BNF) provides information about the selection, prescribing, dispensing and administration of drugs.
With over 370 topics to choose from, clinical knowledge summaries (CKS) can provide quick answers to clinical questions.
Our patient decision aids (PDAs) include treatment options available, likely outcomes, benefits, harms and uncertainties.